<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Urokinase.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:13 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Urokinase_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Urokinase_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Urokinase_files/filelist.xml">
<title>UROKINASE</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:12:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:31:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>2021</o:Words>
  <o:Characters>11524</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>96</o:Lines>
  <o:Paragraphs>27</o:Paragraphs>
  <o:CharactersWithSpaces>13518</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>UROKINASE<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;:</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Urokinase.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC: </span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B01A
D04.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c: </span></b><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'>Thu&#7889;c tan huy&#7871;t kh&#7889;i.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7897;t
pha tiêm</span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: 25.000 &#273;vqt, 100.000 &#273;vqt, 300.000 &#273;vqt,
600.000 &#273;vqt.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7897;t
&#273;&#7875; pha d&#7883;ch truy&#7873;n &#273;&#7897;ng m&#7841;ch vành ho&#7863;c
truy&#7873;n t&#297;nh m&#7841;ch,</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> 250.000 &#273;vqt (v&#7899;i albumin
ng&#432;&#7901;i 250 mg, manitol 25 mg, và natri clorid 50 mg) (Abbokinase). <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7897;t
&#273;&#7875; pha dung d&#7883;ch, làm thông catête,</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> 5.000
&#273;vqt, 9.000 &#273;vqt (v&#7899;i gelatin, manitol, natri clorid, và natri
dihydro phosphat khan) (Abbokinase open - Cath).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Urokinase
là m&#7897;t protease có hai m&#7841;ch &#273;&#432;&#7907;c phân l&#7853;p t&#7915;
nuôi c&#7845;y t&#7871; bào th&#7853;n ng&#432;&#7901;i. Ng&#432;&#7907;c l&#7841;i
v&#7899;i các thu&#7889;c ch&#7889;ng &#273;ông ng&#259;n c&#7843;n lan truy&#7873;n
c&#7909;c huy&#7871;t kh&#7889;i, urokinase gây tan huy&#7871;t kh&#7889;i.
Urokinase tác &#273;&#7897;ng tr&#7921;c ti&#7871;p trên h&#7879; tiêu fibrin n&#7897;i
sinh &#273;&#7875; chuy&#7875;n plasminogen thành plasmin là enzym th&#7911;y
phân protein. Plasmin phân gi&#7843;i fibrin, fibrinogen, và nh&#7919;ng
protein tr&#7907; &#273;ông khác trong huy&#7871;t t&#432;&#417;ng. Plasminogen
có trong c&#7909;c huy&#7871;t kh&#7889;i và c&#7909;c ngh&#7869;n m&#7841;ch,
do &#273;ó ho&#7841;t hóa do urokinase di&#7877;n ra bên trong và c&#7843; trên
b&#7873; m&#7863;t c&#7909;c huy&#7871;t kh&#7889;i và c&#7909;c ngh&#7869;n m&#7841;ch.
Tác d&#7909;ng tiêu fibrin c&#7911;a urokinase th&#432;&#7901;ng m&#7845;t
&#273;i trong vòng vài gi&#7901; nh&#432;ng s&#7921; t&#259;ng th&#7901;i gian
thrombin, gi&#7843;m n&#7891;ng &#273;&#7897; fibrinogen và plasminogen trong
huy&#7871;t t&#432;&#417;ng và t&#259;ng n&#7891;ng &#273;&#7897; các s&#7843;n
ph&#7849;m phân h&#7911;y c&#7911;a fibrinogen và fibrin có th&#7875; v&#7851;n
t&#7891;n t&#7841;i t&#7899;i 12 - 24 gi&#7901; sau khi ng&#7915;ng truy&#7873;n
t&#297;nh m&#7841;ch. M&#7863;c dù theo dõi labo là quan tr&#7885;ng &#273;&#7875;
bi&#7871;t ch&#7855;c ch&#7855;n có s&#7921; ho&#7841;t hóa tho&#7843;
&#273;áng h&#7879; tiêu fibrin (ví d&#7909;, th&#7901;i gian thrombin l&#7899;n
h&#417;n hai l&#7847;n tr&#7883; s&#7889; ki&#7875;m ch&#7913;ng bình th&#432;&#7901;ng,
3 - 4 gi&#7901; sau khi b&#7855;t &#273;&#7847;u li&#7879;u pháp), hình
nh&#432; không có s&#7921; t&#432;&#417;ng quan gi&#7919;a m&#7913;c &#273;&#7897;
tiêu huy&#7871;t kh&#7889;i ho&#7863;c nguy c&#417; bi&#7871;n ch&#7913;ng ch&#7843;y
máu v&#7899;i nh&#7919;ng k&#7871;t qu&#7843; &#273;o tác d&#7909;ng c&#7911;a
urokinase trên &#273;ông máu ho&#7863;c trên h&#7879; tiêu fibrin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Urokinase
c&#361;ng gây tác d&#7909;ng ch&#7889;ng &#273;ông do n&#7891;ng &#273;&#7897;
cao c&#7911;a nh&#7919;ng s&#7843;n ph&#7849;m thoái giáng fibrinogen và
fibrin. Trong ngh&#7869;n m&#7841;ch ph&#7893;i, k&#7871;t qu&#7843; ch&#7909;p
X quang m&#7841;ch và &#273;o huy&#7871;t &#273;&#7897;ng ch&#7913;ng minh, li&#7879;u
pháp tan huy&#7871;t kh&#7889;i, tác d&#7909;ng nhanh h&#417;n so v&#7899;i li&#7879;u
pháp heparin. Trong huy&#7871;t kh&#7889;i &#273;&#7897;ng m&#7841;ch vành, ph&#7847;n
l&#7899;n ng&#432;&#7901;i b&#7879;nh &#273;&#432;&#7907;c truy&#7873;n &#273;&#7897;ng
m&#7841;ch vành urokinase, trong vòng 6 gi&#7901; sau khi x&#7843;y ra tri&#7879;u
ch&#7913;ng, có l&#432;u thông máu tr&#7903; l&#7841;i &#7903; m&#7841;ch b&#7883;
huy&#7871;t kh&#7889;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hi&#7879;n
nay s&#7921; quan tâm &#273;&#7871;n urokinase gi&#7843;m &#273;i vì thu&#7889;c
này có nh&#7919;ng b&#7845;t l&#7907;i c&#7911;a c&#7843; hai thu&#7889;c tan
huy&#7871;t kh&#7889;i khác hi&#7879;n có. Gi&#7889;ng nh&#432; streptokinase,
urokinase thi&#7871;u tính &#273;&#7863;c hi&#7879;u &#273;&#7889;i v&#7899;i
fibrin và do &#273;ó d&#7877; gây tr&#7841;ng thái phân gi&#7843;i &#7903; toàn
c&#417; th&#7875;; gi&#7889;ng nh&#432; t - PA (alteplase), urokinase r&#7845;t
&#273;&#7855;t ti&#7873;n. Prourokinase, là urokinase có m&#7897;t m&#7841;ch,
có tính ch&#7885;n l&#7885;c &#273;&#7889;i v&#7899;i c&#7909;c &#273;ông máu
do g&#7855;n v&#7899;i fibrin tr&#432;&#7899;c khi ho&#7841;t hóa.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
font-weight:normal'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c <o:p></o:p></span></i></h2>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
font-weight:normal'>Urokinase không &#273;&#432;&#7907;c h&#7845;p th&#7909;
qua &#273;&#432;&#7901;ng tiêu hóa. Sau khi truy&#7873;n t&#297;nh m&#7841;ch,
thu&#7889;c thanh th&#7843;i nhanh kh&#7887;i tu&#7847;n hoàn. Trong nghiên c&#7913;u
v&#7899;i urokinase có g&#7855;n phóng x&#7841;, d&#432;&#7899;i 25% ho&#7841;t
tính phóng x&#7841; tiêm vào &#7903; l&#7841;i trong máu và ph&#7847;n l&#7899;n
ho&#7841;t tính phóng x&#7841; xu&#7845;t hi&#7879;n trong gan và bàng quang.
Sau khi tiêm t&#297;nh m&#7841;ch, urokinase có n&#7917;a &#273;&#7901;i huy&#7871;t
t&#432;&#417;ng 10 - 20 phút và &#273;&#432;&#7907;c chuy&#7875;n hóa ch&#7911;
y&#7871;u &#7903; gan. &#7902; ng&#432;&#7901;i suy gi&#7843;m ch&#7913;c
n&#259;ng gan, n&#7917;a &#273;&#7901;i huy&#7871;t t&#432;&#417;ng có th&#7875;
t&#259;ng. M&#7897;t l&#432;&#7907;ng nh&#7887; urokinase bài ti&#7871;t qua
n&#432;&#7899;c ti&#7875;u và qua m&#7853;t.<o:p></o:p></span></h2>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ngh&#7869;n
m&#7841;ch ph&#7893;i.</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Urokinase
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh cho ng&#432;&#7901;i l&#7899;n
&#273;&#7875;: làm tiêu c&#7909;c ngh&#7869;n m&#7841;ch ph&#7893;i r&#7845;t l&#7899;n,
c&#7845;p tính, gây t&#7855;c dòng máu t&#7899;i m&#7897;t thùy ho&#7863;c nhi&#7873;u
phân thùy; làm tiêu c&#7909;c ngh&#7869;n m&#7841;ch ph&#7893;i kèm theo huy&#7871;t
&#273;&#7897;ng không &#7893;n &#273;&#7883;nh, ngh&#297;a là không duy trì
&#273;&#432;&#7907;c huy&#7871;t áp khi không có bi&#7879;n pháp h&#7895; tr&#7907;.
Xác minh ch&#7849;n &#273;oán b&#7857;ng nh&#7919;ng bi&#7879;n pháp khách quan
nh&#432; ch&#7909;p m&#7841;ch ph&#7893;i qua m&#7897;t t&#297;nh m&#7841;ch &#7903;
chi trên, ho&#7863;c nh&#7919;ng ph&#432;&#417;ng pháp không xâm h&#7841;i
nh&#432; ch&#7909;p c&#7855;t l&#7899;p ph&#7893;i. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
kh&#7889;i &#273;&#7897;ng m&#7841;ch vành</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Urokinase
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh &#273;&#7875; làm tiêu c&#7909;c
huy&#7871;t kh&#7889;i c&#7845;p tính làm t&#7855;c &#273;&#7897;ng m&#7841;ch
vành trong nh&#7891;i máu c&#417; tim xuyên thành ti&#7871;n tri&#7875;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7888;ng
thông (catête) t&#297;nh m&#7841;ch b&#7883; t&#7855;c.<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Urokinase
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh &#273;&#7875; làm thông &#7889;ng
thông t&#297;nh m&#7841;ch, k&#7875; c&#7843; &#7889;ng thông t&#297;nh m&#7841;ch
trung tâm, b&#7883; t&#7855;c do máu &#273;ông ho&#7863;c fibrin (s&#7907;i huy&#7871;t).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoBodyText2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:150%'><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>M&#7899;i ph&#7851;u thu&#7853;t trong
vòng 10 ngày, k&#7875; c&#7843; sinh thi&#7871;t c&#417; quan, ch&#7885;c m&#7841;ch
máu không ép &#273;&#432;&#7907;c, ch&#7845;n th&#432;&#417;ng n&#7863;ng, h&#7891;i
s&#7913;c tim ph&#7893;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7843;y
máu &#273;&#432;&#7901;ng tiêu hóa n&#7863;ng trong vòng 3 tháng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ti&#7873;n
s&#7917; b&#7879;nh t&#259;ng huy&#7871;t áp (huy&#7871;t áp tâm
tr&#432;&#417;ng &gt; 110 mm Hg).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>R&#7889;i
lo&#7841;n ch&#7843;y máu ho&#7863;c ch&#7843;y máu &#273;ang ho&#7841;t &#273;&#7897;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tai bi&#7871;n
m&#7841;ch máu não tr&#432;&#7899;c &#273;ây ho&#7863;c kh&#7889;i u n&#7897;i
s&#7885; ho&#7841;t &#273;&#7897;ng, &#273;&#7863;c bi&#7879;t ch&#7843;y máu,
và/ho&#7863;c ph&#7851;u thu&#7853;t não ho&#7863;c c&#7897;t s&#7889;ng trong
vòng hai tháng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Phình m&#7841;ch
tách.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viêm
màng ngoài tim c&#7845;p.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
nh&#7919;ng bác s&#7929; có kinh nghi&#7879;m &#273;i&#7873;u tr&#7883; huy&#7871;t
kh&#7889;i m&#7899;i &#273;&#432;&#7907;c dùng urokinase, trong nh&#7919;ng b&#7879;nh
vi&#7879;n có &#273;i&#7873;u ki&#7879;n theo dõi th&#7901;i gian thrombin và
nh&#7919;ng thông s&#7889; lâm sàng và xét nghi&#7879;m c&#7847;n thi&#7871;t
khác. Ph&#7843;i &#273;ánh giá c&#7849;n th&#7853;n tình tr&#7841;ng lâm sàng
toàn thân và ti&#7873;n s&#7917; b&#7879;nh tr&#432;&#7899;c khi b&#7855;t
&#273;&#7847;u li&#7879;u pháp urokinase. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
&#273;ã dùng heparin, ph&#7843;i ng&#7915;ng heparin tr&#432;&#7899;c khi b&#7855;t
&#273;&#7847;u li&#7879;u pháp tan huy&#7871;t kh&#7889;i, tr&#7915; khi
heparin &#273;&#432;&#7907;c dùng k&#7871;t h&#7907;p v&#7899;i urokinase
&#273;&#7875; tiêm truy&#7873;n &#273;&#7897;ng m&#7841;ch vành. Th&#7901;i
gian thrombin ho&#7863;c th&#7901;i gian thromboplastin ho&#7841;t hóa m&#7897;t
ph&#7847;n ph&#7843;i nh&#7887; h&#417;n hai l&#7847;n tr&#7883; s&#7889; ki&#7875;m
ch&#7913;ng bình th&#432;&#7901;ng tr&#432;&#7899;c khi b&#7855;t &#273;&#7847;u
li&#7879;u pháp tan huy&#7871;t kh&#7889;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong
khi truy&#7873;n urokinase, có th&#7875; th&#7921;c hi&#7879;n nh&#7919;ng xét
nghi&#7879;m v&#7873; &#273;ông máu và/ho&#7863;c &#273;o ho&#7841;t tính tiêu
fibrin, n&#7871;u mu&#7889;n. Tuy v&#7853;y, k&#7871;t qu&#7843; xét nghi&#7879;m
không tiên &#273;oán hi&#7879;u l&#7921;c c&#7911;a thu&#7889;c ho&#7863;c nguy
c&#417; ch&#7843;y máu m&#7897;t cách &#273;áng tin c&#7853;y. Ph&#7843;i
th&#432;&#7901;ng xuyên quan sát &#273;áp &#7913;ng lâm sàng, và ph&#7843;i ki&#7875;m
tra nh&#7919;ng d&#7845;u hi&#7879;u quan tr&#7885;ng nh&#432; m&#7841;ch, nhi&#7879;t
&#273;&#7897;, t&#7847;n s&#7889; hô h&#7845;p và huy&#7871;t áp, ít nh&#7845;t
c&#7913; 4 gi&#7901; m&#7897;t l&#7847;n. Không &#273;&#432;&#7907;c &#273;o
huy&#7871;t áp &#7903; chi d&#432;&#7899;i &#273;&#7875; tránh bong c&#7909;c
huy&#7871;t kh&#7889;i có th&#7875; có &#7903; t&#297;nh m&#7841;ch sâu. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Sau khi
truy&#7873;n t&#297;nh m&#7841;ch urokinase, tr&#432;&#7899;c khi dùng l&#7841;i
heparin, th&#7901;i gian thrombin và th&#7901;i gian thromboplastin ho&#7841;t
hóa m&#7897;t ph&#7847;n ph&#7843;i nh&#7887; h&#417;n hai l&#7847;n gi&#7899;i
h&#7841;n trên c&#7911;a tr&#7883; s&#7889; bình th&#432;&#7901;ng. Sau khi
truy&#7873;n &#273;&#7897;ng m&#7841;ch vành urokinase, ph&#7843;i xác &#273;&#7883;nh
nh&#7919;ng thông s&#7889; &#273;ông máu, và ti&#7871;p t&#7909;c li&#7879;u
pháp heparin phù h&#7907;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7902;
ng&#432;&#7901;i có rung nh&#297; ho&#7863;c nh&#7919;ng b&#7879;nh khác có
nguy c&#417; ngh&#7869;n m&#7841;ch não, li&#7879;u pháp urokinase có th&#7875;
nguy hi&#7875;m do nguy c&#417; ch&#7843;y máu &#7903; vùng b&#7883; nh&#7891;i
máu. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nguy
c&#417; do li&#7879;u pháp urokinase có th&#7875; t&#259;ng và ph&#7843;i
&#273;&#432;&#7907;c cân nh&#7855;c v&#7899;i l&#7907;i ích có th&#7875; có c&#7911;a
li&#7879;u pháp này &#7903; ng&#432;&#7901;i m&#7899;i &#273;&#432;&#7907;c
&#273;&#7841;i ph&#7851;u thu&#7853;t (trong vòng 10 ngày), ng&#432;&#7901;i có
ch&#7843;y máu &#273;&#432;&#7901;ng tiêu hóa n&#7863;ng, ng&#432;&#7901;i có
làm sinh thi&#7871;t c&#417; quan, sinh &#273;&#7867;, ho&#7863;c tr&#432;&#7899;c
&#273;ây ch&#7885;c m&#7841;ch máu không ép &#273;&#432;&#7907;c và ng&#432;&#7901;i
có nguy c&#417; cao huy&#7871;t kh&#7889;i tim trái (ví d&#7909;, h&#7865;p van
hai lá v&#7899;i rung nh&#297;), viêm màng trong tim nhi&#7877;m khu&#7849;n,
mang thai, b&#7879;nh m&#7841;ch não, b&#7879;nh võng m&#7841;c ch&#7843;y máu,
&#273;ái tháo &#273;&#432;&#7901;ng, ho&#7863;c nh&#7919;ng khi&#7871;m khuy&#7871;t
v&#7873; c&#7847;m máu, k&#7875; c&#7843; do b&#7879;nh gan ho&#7863;c th&#7853;n
n&#7863;ng. Ph&#7843;i dùng urokinase r&#7845;t th&#7853;n tr&#7885;ng trong b&#7845;t
k&#7923; b&#7879;nh nào mà ch&#7843;y máu là m&#7897;t nguy c&#417; &#273;áng k&#7875;
ho&#7863;c &#273;&#7863;c bi&#7879;t khó gi&#7843;i quy&#7871;t do v&#7883; trí
c&#7911;a nó.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cho t&#7899;i
nay ch&#432;a có công trình nghiên c&#7913;u &#273;&#7847;y &#273;&#7911; ho&#7863;c
có ki&#7875;m ch&#7913;ng v&#7873; vi&#7879;c dùng urokinase &#7903; ng&#432;&#7901;i
mang thai, do &#273;ó ch&#7881; nên dùng urokinase trong th&#7901;i k&#7923;
mang thai khi th&#7921;c s&#7921; c&#7847;n thi&#7871;t.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vì không
bi&#7871;t urokinase có phân b&#7889; trong s&#7919;a m&#7865; hay không, nên
ph&#7843;i dùng th&#7853;n tr&#7885;ng thu&#7889;c này &#7903; ng&#432;&#7901;i
cho con bú.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>ADR ch&#7911;
y&#7871;u c&#7911;a t&#7845;t c&#7843; các thu&#7889;c tan huy&#7871;t kh&#7889;i
là ch&#7843;y máu, do hai nhân t&#7889;: tiêu fibrin trong c&#7909;c huy&#7871;t
kh&#7889;i sinh lý &#7903; v&#7883; trí th&#432;&#417;ng t&#7893;n m&#7841;ch
máu; và tr&#7841;ng thái tiêu fibrin toàn thân do s&#7921; t&#7841;o plasmin &#7903;
toàn c&#417; th&#7875;, gây tiêu fibrinogen và phá h&#7911;y nh&#7919;ng y&#7871;u
t&#7889; &#273;ông máu khác (&#273;&#7863;c bi&#7879;t nh&#7919;ng y&#7871;u t&#7889;
V và VIII). <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tình tr&#7841;ng
c&#7847;m máu c&#7911;a ng&#432;&#7901;i b&#7879;nh thay &#273;&#7893;i v&#7899;i
li&#7879;u pháp urokinase nhi&#7873;u h&#417;n so v&#7899;i li&#7879;u pháp
heparin ho&#7863;c các thu&#7889;c ch&#7889;ng &#273;ông thu&#7897;c d&#7851;n
ch&#7845;t coumarin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tim m&#7841;ch:
Gi&#7843;m huy&#7871;t áp, lo&#7841;n nh&#7883;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Da: Phù
th&#7847;n kinh m&#7841;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
h&#7885;c: Ch&#7843;y máu &#7903; n&#417;i ch&#7845;n th&#432;&#417;ng xuyên
da.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7855;t:
S&#432;ng quanh h&#7889; m&#7855;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hô h&#7845;p:
Co th&#7855;t ph&#7871; qu&#7843;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Khác: Ph&#7843;n
v&#7879;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
ADR &lt;1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh trung &#432;&#417;ng: Nh&#7913;c &#273;&#7847;u, rét run.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Da: Ban.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Bu&#7891;n nôn, nôn.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
h&#7885;c: Thi&#7871;u máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7855;t:
Ch&#7843;y máu m&#7855;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hô h&#7845;p:
Ch&#7843;y máu cam.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Khác: Vã
m&#7891; hôi.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng
d&#7851;n cách x&#7917; trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
ch&#7843;y máu &#7903; v&#7883; trí xâm nh&#7853;p không n&#7863;ng, có th&#7875;
ti&#7871;p t&#7909;c li&#7879;u pháp urokinase và theo dõi ch&#7863;t ch&#7869;
ng&#432;&#7901;i b&#7879;nh; nh&#7919;ng bi&#7879;n pháp c&#7909;c b&#7897;
nh&#432; b&#259;ng ép ph&#7843;i &#273;&#432;&#7907;c th&#7921;c hi&#7879;n
ngay. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
x&#7843;y ra ch&#7843;y máu t&#7921; phát n&#7863;ng, ph&#7843;i ng&#7915;ng
truy&#7873;n urokinase ngay. Có th&#7875; dùng d&#7883;ch truy&#7873;n
t&#259;ng th&#7875; tích huy&#7871;t t&#432;&#417;ng, tr&#7915; dextran, &#273;&#7875;
b&#7891;i ph&#7909; thi&#7871;u h&#7909;t th&#7875; tích máu; n&#7871;u m&#7845;t
máu nhi&#7873;u, truy&#7873;n kh&#7889;i h&#7891;ng c&#7847;u &#273;&#432;&#7907;c
dùng h&#417;n là máu toàn b&#7897;. N&#7871;u c&#7847;n &#273;&#7843;o ng&#432;&#7907;c
nhanh tình tr&#7841;ng tiêu fibrin, có th&#7875; dùng thu&#7889;c ch&#7889;ng
tiêu fibrin nh&#432; acid aminocaproic, m&#7863;c dù ch&#432;a có t&#432; li&#7879;u
ch&#7913;ng minh giá tr&#7883; lâm sàng c&#7911;a acid aminocaproic trong ki&#7875;m
soát ch&#7843;y máu sau li&#7879;u pháp urokinase.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; tri&#7879;u ch&#7913;ng th&#432;&#7901;ng &#273;&#7911; &#273;&#7875;
gi&#7843;m nh&#7865; tr&#7841;ng thái khó chi&#7909; do s&#7889;t gây b&#7903;i
urokinase; tuy v&#7853;y <i>không</i> &#273;&#432;&#7907;c dùng aspirin. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>S&#7921;
tiêu nhanh c&#7909;c huy&#7871;t kh&#7889;i &#273;&#7897;ng m&#7841;ch vành
&#273;ôi khi có th&#7875; gây lo&#7841;n nh&#7883;p nh&#297; ho&#7863;c th&#7845;t
do t&#432;&#7899;i máu tr&#7903; l&#7841;i, c&#7847;n ph&#7843;i &#273;i&#7873;u
tr&#7883; ngay.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cách
dùng:</span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'> <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7875;
&#273;i&#7873;u tr&#7883; ngh&#7869;n m&#7841;ch ph&#7893;i, truy&#7873;n t&#297;nh
m&#7841;ch urokinase qua m&#7897;t máy b&#417;m truy&#7873;n. Ð&#7875; &#273;i&#7873;u
tr&#7883; huy&#7871;t kh&#7889;i &#273;&#7897;ng m&#7841;ch vành, truy&#7873;n
urokinase m&#7897;t cách ch&#7885;n l&#7885;c vào &#273;&#7897;ng m&#7841;ch
vành b&#7883; huy&#7871;t kh&#7889;i qua &#7889;ng thông (catête) &#273;&#7897;ng
m&#7841;ch vành. Ð&#7875; thông &#7889;ng thông t&#297;nh m&#7841;ch b&#7883; t&#7855;c,
cho urokinase vào trong &#7889;ng thông.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng: <o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ngh&#7869;n
m&#7841;ch ph&#7893;i:</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7875;
&#273;i&#7873;u tr&#7883; ngh&#7869;n m&#7841;ch ph&#7893;i, li&#7873;u
urokinase th&#432;&#7901;ng dùng là 4.400 &#273;vqt/kg, tiêm t&#297;nh m&#7841;ch
trong th&#7901;i gian 10 phút, ti&#7871;p theo sau là truy&#7873;n t&#297;nh m&#7841;ch
liên t&#7909;c 4.400 &#273;vqt/kg/gi&#7901;, trong 12 gi&#7901;. Nói chung ph&#7843;i
xác &#273;&#7883;nh th&#7901;i gian thrombin 3 - 4 gi&#7901; sau khi b&#7855;t
&#273;&#7847;u li&#7879;u pháp &#273;&#7875; &#273;&#7843;m b&#7843;o có s&#7921;
ho&#7841;t hóa &#273;&#7847;y &#273;&#7911; (ngh&#297;a là th&#7901;i gian
thrombin l&#7899;n h&#417;n hai l&#7847;n tr&#7883; s&#7889; ki&#7875;m ch&#7913;ng
bình th&#432;&#7901;ng) c&#7911;a h&#7879; tiêu fibrin. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vào lúc
cu&#7889;i c&#7911;a li&#7879;u pháp urokinase, c&#7847;n th&#7921;c hi&#7879;n
li&#7879;u pháp ch&#7889;ng &#273;ông b&#7857;ng truy&#7873;n t&#297;nh m&#7841;ch
liên t&#7909;c heparin và dùng m&#7897;t thu&#7889;c ch&#7889;ng &#273;ông u&#7889;ng.
Tuy v&#7853;y, không &#273;&#432;&#7907;c b&#7855;t &#273;&#7847;u li&#7879;u
pháp heparin cho t&#7899;i khi th&#7901;i gian thrombin &#273;ã gi&#7843;m t&#7899;i
m&#7913;c nh&#7887; h&#417;n hai l&#7847;n tr&#7883; s&#7889; ki&#7875;m ch&#7913;ng
bình th&#432;&#7901;ng (th&#432;&#7901;ng kho&#7843;ng 3 - 4 gi&#7901; sau khi
ng&#7915;ng truy&#7873;n urokinase).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
kh&#7889;i &#273;&#7897;ng m&#7841;ch vành và nh&#7891;i máu c&#417; tim</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7879;u
pháp tan huy&#7871;t kh&#7889;i truy&#7873;n &#273;&#7897;ng m&#7841;ch vành
urokinase nói chung &#273;ã &#273;&#432;&#7907;c thay th&#7871; b&#7903;i li&#7879;u
pháp truy&#7873;n t&#297;nh m&#7841;ch thí d&#7909; v&#7899;i alteplase ho&#7863;c
streptokinase. N&#7871;u dùng truy&#7873;n &#273;&#7897;ng m&#7841;ch vành
urokinase &#273;&#7875; &#273;i&#7873;u tr&#7883; huy&#7871;t kh&#7889;i gây t&#7855;c
&#273;&#7897;ng m&#7841;ch vành c&#7845;p, trong nh&#7891;i máu c&#417; tim
xuyên thành ti&#7871;n tri&#7875;n, ph&#7843;i b&#7855;t &#273;&#7847;u li&#7879;u
pháp trong vòng 6 gi&#7901; t&#7915; khi xu&#7845;t hi&#7879;n các tri&#7879;u
ch&#7913;ng. Thêm vào vi&#7879;c theo dõi huy&#7871;t h&#7885;c, ph&#7843;i
theo dõi c&#7849;n th&#7853;n v&#7873; lo&#7841;n nh&#7883;p &#273;&#7889;i v&#7899;i
ng&#432;&#7901;i &#273;&#432;&#7907;c truy&#7873;n &#273;&#7897;ng m&#7841;ch
vành urokinase &#273;&#7875; làm tiêu c&#7909;c huy&#7871;t kh&#7889;i &#273;&#7897;ng
m&#7841;ch vành.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tr&#432;&#7899;c
khi truy&#7873;n &#273;&#7897;ng m&#7841;ch vành urokinase, ph&#7843;i tiêm t&#297;nh
m&#7841;ch nhanh m&#7897;t li&#7873;u heparin 2.500 &#273;&#7871;n 10.000
&#273;&#417;n v&#7883;; n&#7871;u tr&#432;&#7899;c &#273;ó &#273;ã dùng heparin
ph&#7843;i xem xét &#273;&#7875; l&#7921;a ch&#7885;n li&#7873;u. Sau khi
&#273;ã tiêm heparin, truy&#7873;n dung d&#7883;ch urokinase &#273;ã pha vào
&#273;&#7897;ng m&#7841;ch vành b&#7883; huy&#7871;t kh&#7889;i v&#7899;i t&#7889;c
&#273;&#7897; 6.000 &#273;vqt/phút, trong th&#7901;i gian t&#7889;i &#273;a 2
gi&#7901;. Ð&#7875; xác &#273;&#7883;nh &#273;áp &#7913;ng v&#7899;i li&#7879;u
pháp urokinase, c&#7847;n ch&#7909;p m&#7841;ch nhi&#7873;u l&#7847;n, &#7903;
nh&#7919;ng kho&#7843;ng cách 15 phút. Ph&#7843;i ti&#7871;p t&#7909;c li&#7879;u
pháp urokinase cho t&#7899;i khi &#273;&#7897;ng m&#7841;ch &#273;&#432;&#7907;c
m&#7903; thông t&#7889;i &#273;a, th&#432;&#7901;ng 15 - 30 phút sau khi b&#7855;t
&#273;&#7847;u m&#7903;, ho&#7863;c cho t&#7899;i khi &#273;ã truy&#7873;n thu&#7889;c
&#273;&#432;&#7907;c 2 gi&#7901;. Sau khi có &#273;&#432;&#7907;c tình tr&#7841;ng
t&#432;&#7899;i máu tr&#7903; l&#7841;i, nên ti&#7871;p t&#7909;c li&#7879;u
pháp heparin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7888;ng
thông (catête) t&#297;nh m&#7841;ch b&#7883; t&#7855;c: <o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7875;
thông &#7889;ng thông t&#297;nh m&#7841;ch b&#7883; t&#7855;c, tháo &#7889;ng
truy&#7873;n t&#297;nh m&#7841;ch n&#7889;i v&#7899;i tr&#7909;c &#7889;ng
thông m&#7897;t cách vô khu&#7849;n và thay b&#7857;ng m&#7897;t b&#417;m tiêm
tuberculin ch&#7913;a &#273;&#7847;y dung d&#7883;ch urokinase 5.000
&#273;vqt/ml. Tiêm ch&#7853;m và nh&#7865; nhàng vào &#7889;ng thông m&#7897;t
l&#432;&#7907;ng dung d&#7883;ch urokinase b&#7857;ng th&#7875; tích bên trong
c&#7911;a &#7889;ng thông; sau &#273;ó, b&#7887; b&#417;m tiêm tuberculin ra m&#7897;t
cách vô khu&#7849;n và thay b&#7857;ng b&#417;m tiêm 5 ml. Sau ít nh&#7845;t 5
phút, th&#7917; hút dung d&#7883;ch urokinase và c&#7909;c &#273;ông máu còn l&#7841;i
v&#7899;i b&#417;m tiêm 5ml. Th&#7917; hút nhi&#7873;u l&#7847;n, c&#7913; 5
phút m&#7897;t l&#7847;n. N&#7871;u &#7889;ng thông không thông trong vòng 30
phút, có th&#7875; &#273;&#7853;y n&#7855;p &#7889;ng thông và &#273;&#7875;
urokinase &#7903; l&#7841;i trong &#7889;ng thông trong 30 - 60 phút tr&#432;&#7899;c
khi th&#7917; hút l&#7841;i; trong tr&#432;&#7901;ng h&#7907;p khó thông có th&#7875;
c&#7847;n ph&#7843;i tiêm urokinase l&#7847;n th&#7913; hai. Khi &#7889;ng
thông &#273;ã thông, hút 4 - 5 mililít máu &#273;&#7875; &#273;&#7843;m b&#7843;o
&#273;ã l&#7845;y &#273;i h&#7871;t thu&#7889;c và c&#7909;c &#273;ông máu còn
l&#7841;i. Sau &#273;ó t&#432;&#7899;i nh&#7865; nhàng &#7889;ng thông v&#7899;i
dung d&#7883;ch natri clorid 0,9% b&#7857;ng b&#417;m tiêm 10 ml. Ti&#7871;p
theo, b&#7887; b&#417;m tiêm 10 ml ra, và n&#7889;i l&#7841;i &#7889;ng truy&#7873;n
t&#297;nh m&#7841;ch vào tr&#7909;c &#7889;ng thông m&#7897;t cách vô khu&#7849;n.
Ð&#7875; ng&#259;n ng&#7915;a không khí vào &#7889;ng thông &#273;&#7875; m&#7903;,
ng&#432;&#7901;i b&#7879;nh &#273;&#432;&#7907;c h&#432;&#7899;ng d&#7851;n th&#7903;
ra và nh&#7883;n th&#7903; m&#7895;i khi &#7889;ng thông không &#273;&#432;&#7907;c
n&#7889;i v&#7899;i &#7889;ng truy&#7873;n t&#297;nh m&#7841;ch ho&#7863;c
b&#417;m tiêm. Ph&#7843;i tránh áp l&#7921;c quá m&#7913;c khi tiêm urokinase
vào &#7889;ng thông vì áp l&#7921;c nh&#432; v&#7853;y có th&#7875; gây v&#7905;
&#7889;ng thông ho&#7863;c &#273;&#7849;y c&#7909;c &#273;ông máu vào tu&#7847;n
hoàn.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
ch&#7889;ng &#273;ông:</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Không s&#7917; d&#7909;ng &#273;&#7891;ng
th&#7901;i urokinase truy&#7873;n t&#297;nh m&#7841;ch và thu&#7889;c ch&#7889;ng
&#273;ông u&#7889;ng ho&#7863;c heparin vì có th&#7875; làm t&#259;ng nguy
c&#417; ch&#7843;y máu. Tuy v&#7853;y, có th&#7875; c&#7847;n s&#7917; d&#7909;ng
&#273;&#7891;ng th&#7901;i heparin trong khi truy&#7873;n &#273;&#7897;ng m&#7841;ch
vành urokinase: c&#7847;n theo dõi c&#7849;n th&#7853;n s&#7921; ch&#7843;y máu
quá m&#7913;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#7843;nh h&#432;&#7903;ng &#273;&#7871;n ch&#7913;c n&#259;ng ti&#7875;u c&#7847;u:</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Không
dùng &#273;&#7891;ng th&#7901;i urokinase và thu&#7889;c &#7843;nh h&#432;&#7903;ng
&#273;&#7871;n ch&#7913;c n&#259;ng ti&#7875;u c&#7847;u (ví d&#7909;, aspirin,
dipyridamol, indomethacin, phenylbutazon, sulfinpyrazon), &#273;&#7875; tránh
t&#259;ng nguy c&#417; ch&#7843;y máu.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o
qu&#7843;n b&#7897;t urokinase &#273;&#7875; tiêm &#7903; 2 - 8<sup>0</sup>C,
và b&#7897;t &#273;&#7875; pha dung d&#7883;ch &#7903; d&#432;&#7899;i 25<sup>0</sup>C.
Tránh không &#273;&#7875; b&#7897;t &#273;&#7875; pha dung d&#7883;ch &#273;óng
b&#259;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Sau khi
pha v&#7899;i n&#432;&#7899;c vô khu&#7849;n &#273;&#7875; tiêm, dung d&#7883;ch
urokinase ph&#7843;i dùng ngay và ph&#7847;n dung d&#7883;ch không dùng ph&#7843;i
lo&#7841;i b&#7887;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nh&#7919;ng
tri&#7879;u ch&#7913;ng quá li&#7873;u g&#7891;m ch&#7843;y máu cam, ch&#7843;y
máu l&#7907;i, kh&#7889;i t&#7909; máu, b&#7847;m máu t&#7921; phát, r&#7881;
máu &#7903; n&#417;i &#273;&#7863;t &#7889;ng thông.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong
tr&#432;&#7901;ng h&#7907;p quá li&#7873;u, ph&#7843;i ng&#7915;ng truy&#7873;n
urokinase, và &#273;i&#7873;u tr&#7883; ch&#7843;y máu v&#7899;i nh&#7919;ng ch&#7871;
ph&#7849;m máu, chúng ch&#7913;a các y&#7871;u t&#7889; &#273;ông máu.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Urokinase.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:13 GMT -->
</html>
